Pathstone Family Office’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9
| Closed | – | – | 857 |
|
|
2020
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 1177 |
|
|
2020
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 860 |
|
|
2020
Q2 | $0 | Sell |
9
-65
| -88% | – | ﹤0.01% | 791 |
|
|
2020
Q1 | $2K | Buy |
+74
| New | +$2K | ﹤0.01% | 686 |
|
|
2019
Q2 | – | Sell |
-60
| Closed | -$2K | – | 708 |
|
|
2019
Q1 | $2K | Hold |
60
| – | – | ﹤0.01% | 758 |
|
|
2018
Q4 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 414 |
|